202 related articles for article (PubMed ID: 25452327)
1. Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene therapy approach.
Sarkar S; Quinn BA; Shen X; Dent P; Das SK; Emdad L; Sarkar D; Fisher PB
Mol Pharmacol; 2015 Feb; 87(2):286-95. PubMed ID: 25452327
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer terminator virus.
Sarkar S; Azab B; Quinn BA; Shen X; Dent P; Klibanov AL; Emdad L; Das SK; Sarkar D; Fisher PB
Curr Mol Med; 2014 Jan; 14(1):125-40. PubMed ID: 24236457
[TBL] [Abstract][Full Text] [Related]
3. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.
Lebedeva IV; Su ZZ; Sarkar D; Gopalkrishnan RV; Waxman S; Yacoub A; Dent P; Fisher PB
Oncogene; 2005 Jan; 24(4):585-96. PubMed ID: 15580305
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis.
Lebedeva IV; Su ZZ; Vozhilla N; Chatman L; Sarkar D; Dent P; Athar M; Fisher PB
Mol Cancer Ther; 2008 Jul; 7(7):2042-50. PubMed ID: 18645014
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl alcohol.
Lebedeva IV; Su ZZ; Vozhilla N; Chatman L; Sarkar D; Dent P; Athar M; Fisher PB
Cancer Res; 2008 Sep; 68(18):7439-47. PubMed ID: 18768668
[TBL] [Abstract][Full Text] [Related]
6. mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer.
Chada S; Bocangel D; Ramesh R; Grimm EA; Mumm JB; Mhashilkar AM; Zheng M
Mol Ther; 2005 May; 11(5):724-33. PubMed ID: 15851011
[TBL] [Abstract][Full Text] [Related]
7. Melanoma differentiation associated gene-7, mda-7/interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species.
Lebedeva IV; Su ZZ; Sarkar D; Kitada S; Dent P; Waxman S; Reed JC; Fisher PB
Cancer Res; 2003 Dec; 63(23):8138-44. PubMed ID: 14678967
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention gene therapy (CGT): novel combinatorial approach for preventing and treating pancreatic cancer.
Sarkar S; Azab BM; Das SK; Quinn BA; Shen X; Dash R; Emdad L; Thomas S; Dasgupta S; Su ZZ; Wang XY; Sarkar D; Fisher PB
Curr Mol Med; 2013 Aug; 13(7):1140-59. PubMed ID: 23157679
[TBL] [Abstract][Full Text] [Related]
9. Molecular target-based therapy of pancreatic cancer.
Lebedeva IV; Sarkar D; Su ZZ; Gopalkrishnan RV; Athar M; Randolph A; Valerie K; Dent P; Fisher PB
Cancer Res; 2006 Feb; 66(4):2403-13. PubMed ID: 16489047
[TBL] [Abstract][Full Text] [Related]
10. Local and systemic inhibition of lung tumor growth after nanoparticle-mediated mda-7/IL-24 gene delivery.
Ramesh R; Ito I; Saito Y; Wu Z; Mhashikar AM; Wilson DR; Branch CD; Roth JA; Chada S
DNA Cell Biol; 2004 Dec; 23(12):850-7. PubMed ID: 15684712
[TBL] [Abstract][Full Text] [Related]
11. mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review).
Lebedeva IV; Emdad L; Su ZZ; Gupta P; Sauane M; Sarkar D; Staudt MR; Liu SJ; Taher MM; Xiao R; Barral P; Lee SG; Wang D; Vozhilla N; Park ES; Chatman L; Boukerche H; Ramesh R; Inoue S; Chada S; Li R; De Pass AL; Mahasreshti PJ; Dmitriev IP; Curiel DT; Yacoub A; Grant S; Dent P; Senzer N; Nemunaitis JJ; Fisher PB
Int J Oncol; 2007 Nov; 31(5):985-1007. PubMed ID: 17912425
[TBL] [Abstract][Full Text] [Related]
12. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells.
Dash R; Dmitriev I; Su ZZ; Bhutia SK; Azab B; Vozhilla N; Yacoub A; Dent P; Curiel DT; Sarkar D; Fisher PB
Cancer Gene Ther; 2010 Jul; 17(7):447-56. PubMed ID: 20150932
[TBL] [Abstract][Full Text] [Related]
13. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis.
Sauane M; Su ZZ; Dash R; Liu X; Norris JS; Sarkar D; Lee SG; Allegood JC; Dent P; Spiegel S; Fisher PB
J Cell Physiol; 2010 Mar; 222(3):546-55. PubMed ID: 19937735
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.
Hamed HA; Yacoub A; Park MA; Archer K; Das SK; Sarkar D; Grant S; Fisher PB; Dent P
Mol Pharmacol; 2013 Aug; 84(2):171-81. PubMed ID: 23661648
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells.
Sieger KA; Mhashilkar AM; Stewart A; Sutton RB; Strube RW; Chen SY; Pataer A; Swisher SG; Grimm EA; Ramesh R; Chada S
Mol Ther; 2004 Mar; 9(3):355-67. PubMed ID: 15006602
[TBL] [Abstract][Full Text] [Related]
16. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells.
Azab B; Dash R; Das SK; Bhutia SK; Shen XN; Quinn BA; Sarkar S; Wang XY; Hedvat M; Dmitriev IP; Curiel DT; Grant S; Dent P; Reed JC; Pellecchia M; Sarkar D; Fisher PB
J Cell Physiol; 2012 May; 227(5):2145-53. PubMed ID: 21780116
[TBL] [Abstract][Full Text] [Related]
17. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells.
Su Z; Emdad L; Sauane M; Lebedeva IV; Sarkar D; Gupta P; James CD; Randolph A; Valerie K; Walter MR; Dent P; Fisher PB
Oncogene; 2005 Nov; 24(51):7552-66. PubMed ID: 16044151
[TBL] [Abstract][Full Text] [Related]
18. Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy.
Xu Y; Zhang F; Qin L; Miao J; Sheng W; Xie Y; Xu X; Yang J; Qian H
Melanoma Res; 2014 Feb; 24(1):20-31. PubMed ID: 24300090
[TBL] [Abstract][Full Text] [Related]
19. Heat-shock protein 90 inhibitors synergistically enhance melanoma differentiation-associated gene-7-mediated cell killing of human pancreatic carcinoma.
Zhang Z; Kawamura K; Jiang Y; Shingyoji M; Ma G; Li Q; Hu J; Qi Y; Liu H; Zhang F; Kang S; Shan B; Wang S; Chada S; Tagawa M
Cancer Gene Ther; 2013 Dec; 20(12):663-70. PubMed ID: 24263157
[TBL] [Abstract][Full Text] [Related]
20. Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma.
Leath CA; Kataram M; Bhagavatula P; Gopalkrishnan RV; Dent P; Fisher PB; Pereboev A; Carey D; Lebedeva IV; Haisma HJ; Alvarez RD; Curiel DT; Mahasreshti PJ
Gynecol Oncol; 2004 Aug; 94(2):352-62. PubMed ID: 15297172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
